In a similar vein, there has been a major effort to develop inhibitors of IDO1 to prevent the immune-suppressant activity of this enzyme and thus to drive tumor cell death or to facilitate the effects of anti-tumor drugs (231–235). Here, IDO1 is linked to neoplasm.